Lotus Eye Hospital and Institute Limited (BOM:532998)
India
· Delayed Price · Currency is INR 66.45
+0.67 (1.02%)
At close: Apr 17, 2025
BOM:532998 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 489.33 | 482.1 | 470.44 | 389.1 | 323.59 | 405.53 | Upgrade
|
| Revenue | 489.33 | 482.1 | 470.44 | 389.1 | 323.59 | 405.53 | Upgrade
|
| Revenue Growth (YoY) | 0.90% | 2.48% | 20.91% | 20.24% | -20.21% | 5.54% | Upgrade
|
| Cost of Revenue | 372.44 | 346.44 | 326.07 | 273.31 | 237.89 | 298.38 | Upgrade
|
| Gross Profit | 116.89 | 135.66 | 144.37 | 115.79 | 85.7 | 107.15 | Upgrade
|
| Selling, General & Admin | 34.58 | 34.58 | 34 | 31.53 | 23.41 | 36.25 | Upgrade
|
| Other Operating Expenses | 34.36 | 31.39 | 30.25 | 22.81 | 24.69 | 29.76 | Upgrade
|
| Operating Expenses | 116.05 | 103.24 | 94.05 | 79.36 | 71.4 | 90.97 | Upgrade
|
| Operating Income | 0.85 | 32.42 | 50.32 | 36.43 | 14.3 | 16.18 | Upgrade
|
| Interest Expense | -2.92 | -0.97 | -0.98 | -1.28 | -0.56 | -0.54 | Upgrade
|
| Interest & Investment Income | 4.98 | 4.98 | 4.67 | 4.32 | 3.91 | 4.43 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.54 | 3.66 | 2.52 | 1.56 | 1.47 | 1.41 | Upgrade
|
| EBT Excluding Unusual Items | 5.44 | 40.08 | 56.54 | 41.04 | 19.11 | 21.48 | Upgrade
|
| Other Unusual Items | 0.02 | 0.06 | -0.02 | -0.1 | 0.81 | -6.93 | Upgrade
|
| Pretax Income | 5.46 | 40.14 | 56.52 | 40.94 | 19.92 | 14.56 | Upgrade
|
| Income Tax Expense | 0.35 | 10.99 | 15.75 | 11.09 | 4.24 | 3.91 | Upgrade
|
| Net Income | 5.11 | 29.15 | 40.78 | 29.85 | 15.68 | 10.65 | Upgrade
|
| Net Income to Common | 5.11 | 29.15 | 40.78 | 29.85 | 15.68 | 10.65 | Upgrade
|
| Net Income Growth | -85.55% | -28.52% | 36.62% | 90.34% | 47.28% | 50.37% | Upgrade
|
| Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 21 | Upgrade
|
| Shares Change (YoY) | 1.41% | 0.07% | 0.38% | -0.34% | - | -0.13% | Upgrade
|
| EPS (Basic) | 0.24 | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | Upgrade
|
| EPS (Diluted) | 0.24 | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | Upgrade
|
| EPS Growth | -85.75% | -28.57% | 36.11% | 90.98% | 47.28% | 50.57% | Upgrade
|
| Free Cash Flow | - | 0.4 | 12.9 | -2.73 | 22.55 | 25.52 | Upgrade
|
| Free Cash Flow Per Share | - | 0.02 | 0.62 | -0.13 | 1.08 | 1.23 | Upgrade
|
| Dividend Per Share | - | - | 0.500 | 0.500 | 0.500 | - | Upgrade
|
| Gross Margin | 23.89% | 28.14% | 30.69% | 29.76% | 26.48% | 26.42% | Upgrade
|
| Operating Margin | 0.17% | 6.73% | 10.70% | 9.36% | 4.42% | 3.99% | Upgrade
|
| Profit Margin | 1.04% | 6.04% | 8.67% | 7.67% | 4.85% | 2.63% | Upgrade
|
| Free Cash Flow Margin | - | 0.08% | 2.74% | -0.70% | 6.97% | 6.29% | Upgrade
|
| EBITDA | 36.69 | 63.37 | 74.74 | 55.73 | 33.98 | 41.15 | Upgrade
|
| EBITDA Margin | 7.50% | 13.14% | 15.89% | 14.32% | 10.50% | 10.15% | Upgrade
|
| D&A For EBITDA | 35.84 | 30.95 | 24.42 | 19.3 | 19.68 | 24.97 | Upgrade
|
| EBIT | 0.85 | 32.42 | 50.32 | 36.43 | 14.3 | 16.18 | Upgrade
|
| EBIT Margin | 0.17% | 6.73% | 10.70% | 9.36% | 4.42% | 3.99% | Upgrade
|
| Effective Tax Rate | 6.34% | 27.39% | 27.86% | 27.09% | 21.30% | 26.86% | Upgrade
|
| Revenue as Reported | 501.24 | 495.13 | 481.89 | 397.96 | 331.12 | 414.54 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.